← 產業報告目錄

Knee Replacement Surgery Market by Procedure Type (Knee Replacement: Total, Partial, Revision), Product (Implants: Hybrid, Plastic, Metal or Ceramic; Orthobiologic, Braces), Application (Arthritis, Cancer), End User (Clinics, ASCs) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-07-24頁數 270報告編號 MD9440

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global knee replacement surgery market is expected to reach USD 16.17 billion by 2030 from USD 12.00 billion in 2025, at a CAGR of 6.1% from 2025 to 2030. The Knee replacement surgery market is witnessing substantial growth driven by several key factors. A heightened awareness of various treatment modalities, coupled with improved healthcare infrastructure in developing regions, is facilitating an increase in surgical procedures. Additionally, government initiatives and insurance reforms are enhancing both the affordability and accessibility of knee surgeries, further propelling market activity. Notably, the rising incidence of sports-related injuries among the younger population is contributing to the premature onset of knee conditions, thereby expanding the patient demographic that requires surgical intervention. Collectively, these factors are catalyzing the expansion of the global knee replacement surgery market. “The total knee replacement segment held the largest procedure type market share in 2024.” The knee replacement surgery market is divided into total knee replacement, partial knee replacement, revision knee replacement, and other procedure types. In 2024, the total knee replacement (TKR) segment is projected to dominate the market, primarily driven by the rising prevalence of osteoarthritis, particularly within the geriatric population. This trend underscores the growing demand for durable and effective therapeutic interventions such as TKR. Furthermore, enhanced healthcare infrastructure and increasing awareness of treatment options have facilitated broader accessibility to knee implants in both developed and emerging economies. “The osteoarthritis & rheumatoid arthritis segment commanded the largest applications market share in 2024.” The knee replacement surgery market is segmented by application: osteoarthritis & rheumatoid arthritis, degenerative disease, cancers, and other applications. In 2024, the osteoarthritis & rheumatoid arthritis segment held the major share. Degenerative joint diseases and inflammatory conditions, such as arthritis, can be exacerbated during their initial stages due to sedentary behavior, suboptimal postural alignment, and mechanical stress on the joints resulting from routine activities. “The knee implants segment held the largest product market share in 2024.” The knee implants segment represents the predominant share of the knee replacement surgery market. These implants are pivotal in enhancing patients' quality of life by providing long-lasting analgesia and restoring joint mobility. Their preference among orthopedic surgeons and patients alike can be attributed to their high success and satisfaction rates. Continuous advancements in materials—such as biocompatible alloys and polymers—coupled with innovative design enhancements and superior fixation techniques, have increased the reliability and longevity of these implants. Consequently, there has been a notable uptick in their adoption across various clinical settings. “The hospitals segment accounted for the largest end user market share in 2024.” Hospitals command the largest market share in knee treatment surgical products due to their central role in providing advanced and specialized interventions for knee pathologies. They are equipped to perform cutting-edge procedures, such as total knee arthroplasty, positioning themselves as the preferred venues for orthopedic surgeries. Furthermore, hospitals typically have the financial resources and infrastructure necessary to handle complex cases, execute minimally invasive techniques, and deliver comprehensive postoperative care, all of which contribute to sustained demand for knee treatment surgical devices. “The Asia Pacific market is expected to register the highest growth rate during the forecast period.” The knee replacement surgery market covers five key geographies—North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2024, a significant market share for knee treatment surgery devices was held by the market in the North American region, comprising the US and Canada. On the other hand, the Asia Pacific market is estimated to register the highest growth rate during the forecast period. The Asia Pacific region is witnessing unprecedented expansion in the market for knee treatment surgical devices, driven by several key factors. The demographic shift towards an aging population is significant, with increased prevalence of musculoskeletal disorders such as arthritis and osteoporosis particularly evident in nations like Japan, China, and India. This demographic change is compounded by rising disposable incomes and improved access to healthcare services. The region's healthcare infrastructure is rapidly evolving, with investments in advanced technologies such as minimally invasive surgical techniques and robotic-assisted procedures, which are enhancing surgical outcomes and patient recovery times. Moreover, the surge in medical tourism, particularly in India and Thailand, along with proactive government initiatives aimed at bolstering healthcare infrastructure, further catalyzes market growth. These dynamics collectively position the Asia Pacific as a pivotal market for advancements in orthopedic treatment devices. A breakdown of the primary participants referred to for this report is provided below: • By Company Type: Tier 1– 30%, Tier 2– 42%, and Tier 3– 28% • By Designation: Directors– 10%, Managers– 14%, and Others– 76% • By Region: North America– 40%, Europe– 30%, Asia Pacific– 22%, Latin America- 6%, Middle East & Africa- 2% The prominent players in the Knee replacement surgery market are Stryker (US), Johnson & Johnson Services, Inc. (US), Globus Medical, Inc. (US), Medacta International SA (Switzerland), Zimmer Biomet (US), Maxx Orthopedics (US), Enovis Corporation (US), Microport Scientific Corporation (China), B. Braun Melsungen AG (Germany), Meril Life Sciences Pvt. Ltd. (India), Smith & Nephew PLC (UK), and Exactech Inc. (US) Research Coverage This market research report analyzes the knee replacement surgery market along several different segments, such as procedure type, product, application, end user, and region. The report further sheds light on market growth-driving factors, mentions opportunities and threats, and presents an analysis of the competitive rivalry of leading companies. It further studies micro markets by focusing on growth tendencies and predicts revenues for industry segments for five leading geographies, along with corresponding countries. Reasons to Buy the Report The report would assist both small and new businesses in comprehending the market pattern, which can help them grow their market. Businesses procuring the report can implement any one or several of the approaches discussed to extend their market position. This report provides insights on the following pointers: • Key drivers (increasing prevalence of osteoarthritis and rheumatoid arthritis, Increasing adoption of telemedicine and telesurgery, rising demand for minimally invasive procedures, increasing demand for minimally invasive knee surgical procedures, and higher incidence of sports and accident-related orthopedic injuries), restraints (risk and complications associated with knee surgery procedures, high cost of knee treatment surgery and treatments), opportunities (Growing focus on orthobiologics, increasing hospitals and trend towards outpatient care and innovations in robotic-assisted orthopedic surgeries and 3D printing), and challenges (dearth of orthopedic surgeons ) fueling the market growth of knee treatment surgery devices • Product Development/Innovation: In-depth study of emerging technologies, R&D programs, and new product & service launches in the knee replacement surgery market • Market Growth: In-depth insights into remunerative markets report analyze the knee replacement surgery market across varied geographies. • Market Diversification: Detailed analysis of new products, unexplored geographies, latest trends, and investments in the knee replacement surgery market • Competitive Analysis: In-depth analysis of market shares, growth strategies, and services of leading players, such as Zimmer Biomet (US), Stryker (US), Johnson & Johnson Services, Inc. (US), Smith+Nephew PLC (UK), and B. Braun (Germany).
目錄 Table of Contents
1 INTRODUCTION 26 1.1 STUDY OBJECTIVES 26 1.2 MARKET DEFINITION 26 1.3 STUDY SCOPE 27 1.3.1 MARKETS COVERED AND REGIONAL SCOPE 27 1.3.2 INCLUSIONS AND EXCLUSIONS 28 1.3.3 YEARS CONSIDERED 28 1.4 CURRENCY CONSIDERED 29 1.5 STAKEHOLDERS 29 2 RESEARCH METHODOLOGY 30 2.1 RESEARCH DESIGN 30 2.2 RESEARCH DATA 31 2.2.1 SECONDARY RESEARCH 32 2.2.1.1 Key data from secondary sources 33 2.2.2 PRIMARY RESEARCH 33 2.2.2.1 Primary sources 34 2.2.2.2 Key industry insights 35 2.3 MARKET SIZE ESTIMATION 36 2.3.1 BOTTOM-UP APPROACH 38 2.3.1.1 Approach 1: Company revenue estimation approach 38 2.3.1.2 Approach 2: Customer-based market estimation 39 2.3.1.3 Approach 3: Primary interviews 40 2.3.2 TOP-DOWN APPROACH 40 2.4 GROWTH FORECAST 40 2.5 DATA TRIANGULATION AND MARKET BREAKDOWN 42 2.6 MARKET SHARE ASSESSMENT 42 2.7 RESEARCH ASSUMPTIONS 43 2.8 RESEARCH LIMITATIONS 43 2.9 RISK ASSESSMENT 44 3 EXECUTIVE SUMMARY 45 4 PREMIUM INSIGHTS 49 4.1 KNEE REPLACEMENT SURGERY MARKET OVERVIEW 49 4.2 NORTH AMERICA: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT 50 4.3 EUROPE: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE 50 4.4 ASIA PACIFIC: KNEE REPLACEMENT SURGERY MARKET, BY END USER 51 4.5 KNEE REPLACEMENT SURGERY MARKET, BY REGION 51 5 MARKET OVERVIEW 52 5.1 INTRODUCTION 52 5.2 MARKET DYNAMICS 52 5.2.1 DRIVERS 53 5.2.1.1 Increasing prevalence of osteoarthritis and rheumatoid arthritis 53 5.2.1.2 Rising adoption of telemedicine and telesurgery 53 5.2.1.3 Growing demand for minimally invasive knee surgical procedures 54 5.2.1.4 Rise in sports and accident-related knee injuries 54 5.2.1.5 Booming geriatric population and subsequent age-related bone diseases 54 5.2.2 RESTRAINTS 55 5.2.2.1 Risks and complications associated with knee surgical procedures 55 5.2.2.2 High cost of knee replacement surgery products and treatments 55 5.2.3 OPPORTUNITIES 55 5.2.3.1 Growing focus on orthobiologics 55 5.2.3.2 Rising number of hospitals and shift toward outpatient care 56 5.2.3.3 Increasing use of robotics and 3D printing in knee replacement 56 5.2.4 CHALLENGES 57 5.2.4.1 Dearth of orthopedic surgeons 57 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 58 5.4 PRICING ANALYSIS 58 5.4.1 AVERAGE SELLING PRICE, BY PRODUCT 59 5.4.2 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 59 5.4.3 AVERAGE SELLING PRICE TREND, BY REGION 60 5.5 VALUE CHAIN ANALYSIS 61 5.5.1 RESEARCH & PRODUCT DEVELOPMENT 61 5.5.2 RAW MATERIAL PROCUREMENT 61 5.5.3 MARKETING & SALES, DISTRIBUTION, AND POST-SALES SERVICES 62 5.6 SUPPLY CHAIN ANALYSIS 63 5.6.1 MANUFACTURERS 63 5.6.1.1 Prominent companies 63 5.6.1.2 Small and medium-sized enterprises 63 5.6.2 END USERS 63 5.7 ECOSYSTEM ANALYSIS 64 5.8 INVESTMENT AND FUNDING SCENARIO 65   5.9 TECHNOLOGY ANALYSIS 66 5.9.1 KEY TECHNOLOGIES 66 5.9.1.1 3D printed implants/Additive manufacturing 66 5.9.2 COMPLEMENTARY TECHNOLOGIES 67 5.9.2.1 Robotic-assisted surgery 67 5.9.3 ADJACENT TECHNOLOGIES 67 5.9.3.1 Smart implants and sensors 67 5.10 PATENT ANALYSIS 68 5.11 TRADE ANALYSIS 69 5.11.1 IMPORT DATA FOR HS CODE 902110 69 5.11.2 EXPORT DATA FOR HS CODE 902110 70 5.12 KEY CONFERENCES AND EVENTS, 2025–2026 72 5.13 CASE STUDY ANALYSIS 73 5.13.1 CASE STUDY 1: ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION AND CHONDROPLASTY OF KNEE 73 5.13.2 CASE STUDY 2: BILATERAL TOTAL KNEE REPLACEMENT IN FUNCTIONALLY IMMOBILE PATIENT WITH TRICOMPARTMENTAL ARTHRITIS 73 5.13.3 CASE STUDY 3: RIGHT TOTAL KNEE ARTHROPLASTY FOR IMPROVED MOTION RANGE 74 5.14 PORTER’S FIVE FORCES ANALYSIS 74 5.14.1 BARGAINING POWER OF SUPPLIERS 75 5.14.2 BARGAINING POWER OF BUYERS 75 5.14.3 THREAT OF NEW ENTRANTS 76 5.14.4 THREAT OF SUBSTITUTES 76 5.14.5 INTENSITY OF COMPETITIVE RIVALRY 76 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA 76 5.15.1 KEY STAKEHOLDERS 76 5.15.2 KEY BUYING CRITERIA 77 5.16 UNMET NEEDS 78 5.17 IMPACT OF AI/GEN AI 78 5.17.1 INTRODUCTION 78 5.17.2 MARKET POTENTIAL OF AI ON KNEE REPLACEMENT SURGERY MARKET 78 5.17.3 AI USE CASES 79 5.17.4 KEY COMPANIES IMPLEMENTING AI 79 5.18 IMPACT OF 2025 US TARIFF 80 5.18.1 INTRODUCTION 80 5.18.2 KEY TARIFF RATES 80 5.18.3 PRICE IMPACT ANALYSIS 81 5.18.4 IMPACT ON COUNTRY/REGION 81 5.18.4.1 US 81 5.18.4.2 Europe 81 5.18.4.3 Asia Pacific 81 5.18.5 IMPACT ON END-USE INDUSTRIES 81 6 KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT 82 6.1 INTRODUCTION 83 6.2 KNEE IMPLANTS 83 6.2.1 HYBRID IMPLANTS 85 6.2.1.1 Long-term durability and strong initial fixation to contribute to growth 85 6.2.2 PLASTIC IMPLANTS 85 6.2.2.1 Rising number of joint surgeries to accelerate growth 85 6.2.3 METAL IMPLANTS 86 6.2.3.1 Growing need for long-lasting joint replacements to drive market 86 6.2.4 CERAMIC IMPLANTS 87 6.2.4.1 Minimal propensity to induce inflammation to facilitate growth 87 6.3 ORTHOBIOLOGICS 88 6.3.1 BONE MARROW ASPIRATE CONCENTRATE 88 6.3.1.1 Minimally invasive procedure and less downtime to foster growth 88 6.3.2 VISCOSUPPLEMENTATION PRODUCTS 89 6.3.2.1 Rising occurrence of osteoarthritis to favor growth 89 6.3.3 DEMINERALIZED BONE MATRIX 90 6.3.3.1 Suitability for intricate operations to facilitate growth 90 6.3.4 PLATELET-RICH PLASMA 91 6.3.4.1 Rising application of platelet-rich plasma in sports injuries to support growth 91 6.3.5 BONE MORPHOGENETIC PROTEINS 91 6.3.5.1 Essential role in joint reconstructive surgery to aid growth 91 6.4 KNEE BRACES & SUPPORT SYSTEMS 92 6.4.1 GROWING GERIATRIC AND OBESE POPULATIONS TO PROPEL MARKET 92 7 KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE 94 7.1 INTRODUCTION 95 7.2 TOTAL KNEE REPLACEMENT 96 7.2.1 ONGOING INNOVATIONS IN KNEE IMPLANTS TO EXPEDITE GROWTH 96 7.3 PARTIAL KNEE REPLACEMENT DEVICES 97 7.3.1 QUICK RECOVERY AND SHORTER HOSPITAL STAYS TO AID GROWTH 97 7.4 REVISION KNEE REPLACEMENT 97 7.4.1 RISING INCIDENCE OF OBESITY AND ADVANCEMENTS IN REVISION SURGICAL TECHNOLOGY TO FACILITATE GROWTH 97 7.5 OTHER KNEE REPLACEMENT PROCEDURES 98   8 KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION 100 8.1 INTRODUCTION 101 8.2 RHEUMATOID ARTHRITIS & OSTEOARTHRITIS 101 8.2.1 RISING POOL OF ELDERLY PATIENTS TO AUGMENT GROWTH 101 8.3 DEGENERATIVE DISEASES 102 8.3.1 GROWING IMPACT OF SECONDARY KNEE CONDITIONS TO DRIVE MARKET 102 8.4 CANCERS 103 8.4.1 GROWING BURDEN OF BONE CANCER TO PROPEL MARKET 103 8.5 OTHER APPLICATIONS 104 9 KNEE REPLACEMENT SURGERY MARKET, BY END USER 105 9.1 INTRODUCTION 106 9.2 HOSPITALS 106 9.2.1 GROWING INVESTMENTS IN HOSPITAL INFRASTRUCTURE TO BOOST MARKET 106 9.3 AMBULATORY SURGERY CENTERS 107 9.3.1 INCREASING PREFERENCE FOR COST-EFFECTIVE TREATMENT TO PROMOTE GROWTH 107 9.4 ORTHOPEDIC CLINICS 108 9.4.1 LIMITED HOSPITALIZATION TIME, LOWER COSTS, AND EFFECTIVE POST-OPERATIVE CARE TO SUPPORT GROWTH 108 10 KNEE REPLACEMENT SURGERY MARKET, BY REGION 110 10.1 INTRODUCTION 111 10.2 NORTH AMERICA 111 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 112 10.2.2 US 116 10.2.2.1 Increasing incidence of osteoarthritis and rheumatoid arthritis market to promote growth 116 10.2.3 CANADA 119 10.2.3.1 Rising incidence of degenerative bone diseases to support growth 119 10.3 EUROPE 122 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 122 10.3.2 GERMANY 126 10.3.2.1 Growing demand for advanced medical technology to drive market 126 10.3.3 FRANCE 129 10.3.3.1 Rising prevalence of musculoskeletal disorders to contribute to growth 129 10.3.4 UK 132 10.3.4.1 Increasing awareness of orthopedic conditions to favor growth 132 10.3.5 ITALY 135 10.3.5.1 Growing awareness of preventive care for musculoskeletal injuries to fuel market 135   10.3.6 SPAIN 137 10.3.6.1 Rising preference for minimally invasive surgical procedures to aid growth 137 10.3.7 REST OF EUROPE 140 10.4 ASIA PACIFIC 143 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 144 10.4.2 JAPAN 149 10.4.2.1 Rapidly growing geriatric population to boost market 149 10.4.3 CHINA 152 10.4.3.1 Expanding target patient population to fuel market 152 10.4.4 INDIA 155 10.4.4.1 Increasing number of hospitals adopting robotic-assisted joint replacement surgery to aid growth 155 10.4.5 AUSTRALIA 158 10.4.5.1 Favorable government and private initiatives to promote growth 158 10.4.6 SOUTH KOREA 161 10.4.6.1 Increasing research & development funding to spur growth 161 10.4.7 REST OF ASIA PACIFIC 164 10.5 LATIN AMERICA 167 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 167 10.5.2 BRAZIL 171 10.5.2.1 Strong presence of global players to drive market 171 10.5.3 MEXICO 174 10.5.3.1 Favorable investment scenario for medical device manufacturers to bolster growth 174 10.5.4 REST OF LATIN AMERICA 177 10.6 MIDDLE EAST & AFRICA 180 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 180 10.6.2 GCC COUNTRIES 184 10.6.2.1 Growing public-private partnerships to propel market 184 10.6.3 REST OF MIDDLE EAST & AFRICA 187 11 COMPETITIVE LANDSCAPE 191 11.1 OVERVIEW 191 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 191 11.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES 192 11.3 REVENUE ANALYSIS, 2021−2024 193 11.4 MARKET SHARE ANALYSIS, 2024 194 11.5 COMPANY VALUATION AND FINANCIAL METRICS 196 11.6 BRAND/PRODUCT COMPARISON 197 11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 198 11.7.1 STARS 198 11.7.2 EMERGING LEADERS 198 11.7.3 PERVASIVE PLAYERS 198 11.7.4 PARTICIPANTS 198 11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 200 11.7.5.1 Company footprint 200 11.7.5.2 Region footprint 201 11.7.5.3 Product footprint 201 11.7.5.4 Application footprint 202 11.7.5.5 Procedure footprint 203 11.7.5.6 End-user footprint 203 11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 204 11.8.1 PROGRESSIVE COMPANIES 204 11.8.2 RESPONSIVE COMPANIES 204 11.8.3 DYNAMIC COMPANIES 204 11.8.4 STARTING BLOCKS 204 11.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 206 11.8.5.1 Detailed list of key startups/SMEs 206 11.8.5.2 Competitive benchmarking of key startups/SMEs 207 11.9 COMPETITIVE SCENARIO 208 11.9.1 PRODUCT LAUNCHES AND APPROVALS 208 11.9.2 DEALS 209 12 COMPANY PROFILES 211 12.1 KEY PLAYERS 211 12.1.1 ZIMMER BIOMET 211 12.1.1.1 Business overview 211 12.1.1.2 Products offered 212 12.1.1.3 Recent developments 213 12.1.1.3.1 Product launches and approvals 213 12.1.1.3.2 Deals 214 12.1.1.4 MnM view 214 12.1.1.4.1 Key strengths 214 12.1.1.4.2 Strategic choices 214 12.1.1.4.3 Weaknesses and competitive threats 214 12.1.2 STRYKER 215 12.1.2.1 Business overview 215 12.1.2.2 Products offered 216 12.1.2.3 Recent developments 217 12.1.2.3.1 Deals 217 12.1.2.3.2 Expansions 217 12.1.2.4 MnM view 218 12.1.2.4.1 Key strengths 218 12.1.2.4.2 Strategic choices 218 12.1.2.4.3 Weaknesses and competitive threats 218 12.1.3 JOHNSON & JOHNSON MEDTECH 219 12.1.3.1 Business overview 219 12.1.3.2 Products offered 220 12.1.3.3 Recent developments 221 12.1.3.3.1 Deals 221 12.1.3.4 MnM view 221 12.1.3.4.1 Key strengths 221 12.1.3.4.2 Strategic choices 221 12.1.3.4.3 Weaknesses and competitive threats 221 12.1.4 SMITH+NEPHEW 222 12.1.4.1 Business overview 222 12.1.4.2 Products offered 223 12.1.4.3 Recent developments 224 12.1.4.3.1 Product launches and approvals 224 12.1.4.3.2 Deals 224 12.1.4.3.3 Expansions 224 12.1.4.4 MnM view 225 12.1.4.4.1 Key strengths 225 12.1.4.4.2 Strategic choices 225 12.1.4.4.3 Weaknesses and competitive threats 225 12.1.5 B. BRAUN SE 226 12.1.5.1 Business overview 226 12.1.5.2 Products offered 227 12.1.5.3 Recent developments 228 12.1.5.3.1 Deals 228 12.1.5.4 MnM view 228 12.1.5.4.1 Key strengths 228 12.1.5.4.2 Strategic choices 228 12.1.5.4.3 Weaknesses and competitive threats 229 12.1.6 GLOBUS MEDICAL 230 12.1.6.1 Business overview 230 12.1.6.2 Products offered 231 12.1.6.3 Recent developments 232 12.1.6.3.1 Product launches and approvals 232 12.1.6.3.2 Deals 232 12.1.7 ENOVIS 233 12.1.7.1 Business overview 233 12.1.7.2 Products offered 234 12.1.7.3 Recent developments 236 12.1.7.3.1 Product launches and approvals 236 12.1.7.3.2 Deals 236 12.1.7.3.3 Expansions 237 12.1.8 MICROPORT SCIENTIFIC CORPORATION 238 12.1.8.1 Business overview 238 12.1.8.2 Products offered 239 12.1.8.3 Recent developments 240 12.1.8.3.1 Deals 240 12.1.9 MEDACTA INTERNATIONAL 241 12.1.9.1 Business overview 241 12.1.9.2 Products offered 242 12.1.9.3 Recent developments 243 12.1.9.3.1 Deals 243 12.1.9.3.2 Expansions 243 12.1.10 MAXX ORTHOPEDICS, INC. 244 12.1.10.1 Business overview 244 12.1.10.2 Products offered 244 12.1.10.3 Recent developments 244 12.1.10.3.1 Product launches and approvals 244 12.1.10.3.2 Deals 245 12.1.11 MERIL LIFE SCIENCES PVT. LTD. 246 12.1.11.1 Business overview 246 12.1.11.2 Products offered 246 12.1.11.3 Recent developments 247 12.1.11.3.1 Expansions 247 12.1.12 WALDEMAR LINK GMBH & CO. KG 248 12.1.12.1 Business overview 248 12.1.12.2 Products offered 248 12.1.13 EXACTECH, INC. 249 12.1.13.1 Business overview 249 12.1.13.2 Products offered 249 12.1.13.3 Recent developments 250 12.1.13.3.1 Product launches and approvals 250 12.1.13.3.2 Deals 250 12.1.14 AMPLITUDE SURGICAL 251 12.1.14.1 Business overview 251 12.1.14.2 Products offered 251 12.1.14.3 Recent developments 252 12.1.14.3.1 Deals 252 12.1.15 RESTOR3D 253 12.1.15.1 Business overview 253 12.1.15.2 Products offered 253 12.1.15.3 Recent developments 253 12.1.15.3.1 Product launches and approvals 253 12.2 OTHER PLAYERS 254 12.2.1 BAUERFEIND 254 12.2.2 AK MEDICAL 255 12.2.3 DOUBLE MEDICAL TECHNOLOGY INC. 256 12.2.4 OLYMPUS CORPORATION 257 12.2.5 BIORAD MEDISYS PVT. LTD. 258 12.2.6 UNITED ORTHOPEDIC CORPORATION 259 12.2.7 ALLEGRA 260 12.2.8 TOTAL JOINT ORTHOPEDICS 260 12.2.9 THUASNE GROUP 261 12.2.10 EMBLA MEDICAL 262 13 APPENDIX 263 13.1 DISCUSSION GUIDE 263 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 266 13.3 CUSTOMIZATION OPTIONS 268 13.4 RELATED REPORTS 268 13.5 AUTHOR DETAILS 269
圖表清單 List of Tables & Figures
TABLE 1 KNEE REPLACEMENT SURGERY MARKET: INCLUSIONS AND EXCLUSIONS 28 TABLE 2 KNEE REPLACEMENT SURGERY MARKET: RISK ASSESSMENT 44 TABLE 3 AVERAGE SELLING PRICE TREND OF KNEE IMPLANTS, BY KEY PLAYER, 2022–2024 (USD) 59 TABLE 4 AVERAGE SELLING PRICE TREND OF KNEE SURGERY PRODUCTS, BY REGION, 2022–2024 (USD) 61 TABLE 5 KNEE REPLACEMENT SURGERY MARKET: ROLE OF COMPANIES IN ECOSYSTEM 65 TABLE 6 KNEE REPLACEMENT SURGERY MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2025 69 TABLE 7 IMPORT DATA FOR HS CODE 902110, BY COUNTRY, 2021–2024 (USD THOUSAND) 70 TABLE 8 EXPORT DATA FOR HS CODE 902110, BY COUNTRY, 2021–2024 (USD THOUSAND) 71 TABLE 9 KNEE REPLACEMENT SURGERY MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 72 TABLE 10 KNEE REPLACEMENT SURGERY MARKET: PORTER’S FIVE FORCES ANALYSIS 74 TABLE 11 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT (%) 77 TABLE 12 KEY BUYING CRITERIA, BY END USER 77 TABLE 13 KNEE REPLACEMENT SURGERY MARKET: UNMET NEEDS 78 TABLE 14 KNEE REPLACEMENT SURGERY MARKET: COMPANIES IMPLEMENTING AI 79 TABLE 15 US ADJUSTED RECIPROCAL TARIFF RATES 80 TABLE 16 KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 83 TABLE 17 KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 84 TABLE 18 KNEE IMPLANTS MARKET, BY REGION, 2023–2030 (USD MILLION) 84 TABLE 19 HYBRID IMPLANTS MARKET, BY REGION, 2023–2030 (USD MILLION) 85 TABLE 20 PLASTIC IMPLANTS MARKET, BY REGION, 2023–2030 (USD MILLION) 86 TABLE 21 METAL IMPLANTS MARKET, BY REGION, 2023–2030 (USD MILLION) 86 TABLE 22 CERAMIC IMPLANTS MARKET, BY REGION, 2023–2030 (USD MILLION) 87 TABLE 23 ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 88 TABLE 24 BONE MARROW ASPIRATE CONCENTRATE MARKET, BY REGION, 2023–2030 (USD MILLION) 89 TABLE 25 VISCOSUPPLEMENTATION PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 90 TABLE 26 DEMINERALIZED BONE MATRIX MARKET, BY REGION, 2023–2030 (USD MILLION) 90 TABLE 27 PLATELET-RICH PLASMA MARKET, BY REGION, 2023–2030 (USD MILLION) 91 TABLE 28 BONE MORPHOGENETIC PROTEINS MARKET, BY REGION, 2023–2030 (USD MILLION) 92 TABLE 29 KNEE BRACES & SUPPORT SYSTEMS MARKET, BY REGION, 2023–2030 (USD MILLION) 93 TABLE 30 KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 95 TABLE 31 KNEE REPLACEMENT SURGERY MARKET, BY REGION, 2023–2030 (USD MILLION) 95 TABLE 32 KNEE REPLACEMENT SURGERY PROCEDURES, BY REGION, 2022–2024 (VOLUME UNIT) 96 TABLE 33 TOTAL KNEE REPLACEMENT PROCEDURES MARKET, BY REGION, 2023–2030 (USD MILLION) 96 TABLE 34 PARTIAL KNEE REPLACEMENT PROCEDURES MARKET, BY REGION, 2023–2030 (USD MILLION) 97 TABLE 35 REVISION KNEE REPLACEMENT PROCEDURES MARKET, BY REGION, 2023–2030 (USD MILLION) 98 TABLE 36 OTHER KNEE REPLACEMENT PROCEDURES MARKET, BY REGION, 2023–2030 (USD MILLION) 99 TABLE 37 KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 101 TABLE 38 KNEE REPLACEMENT SURGERY MARKET FOR RHEUMATOID ARTHRITIS & OSTEOARTHRITIS, BY REGION, 2023–2030 (USD MILLION) 102 TABLE 39 KNEE REPLACEMENT SURGERY MARKET FOR DEGENERATIVE DISEASES, BY REGION, 2023–2030 (USD MILLION) 103 TABLE 40 KNEE REPLACEMENT SURGERY MARKET FOR CANCERS, BY REGION, 2023–2030 (USD MILLION) 104 TABLE 41 KNEE REPLACEMENT SURGERY MARKET FOR OTHER APPLICATIONS, BY REGION, 2023–2030 (USD MILLION) 104 TABLE 42 KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 106 TABLE 43 KNEE REPLACEMENT SURGERY MARKET FOR HOSPITALS, BY REGION, 2023–2030 (USD MILLION) 107 TABLE 44 KNEE REPLACEMENT SURGERY MARKET FOR AMBULATORY SURGERY CENTERS, BY REGION, 2023–2030 (USD MILLION) 108 TABLE 45 KNEE REPLACEMENT SURGERY MARKET FOR ORTHOPEDIC CLINICS, BY REGION, 2023–2030 (USD MILLION) 109 TABLE 46 KNEE REPLACEMENT SURGERY MARKET, BY REGION, 2023–2030 (USD MILLION) 111 TABLE 47 NORTH AMERICA: MACROECONOMIC OUTLOOK 112 TABLE 48 NORTH AMERICA: KNEE REPLACEMENT SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 113 TABLE 49 NORTH AMERICA: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 114 TABLE 50 NORTH AMERICA: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 114 TABLE 51 NORTH AMERICA: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 114 TABLE 52 NORTH AMERICA: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 115 TABLE 53 NORTH AMERICA: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 115 TABLE 54 NORTH AMERICA: KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 116 TABLE 55 US: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 117 TABLE 56 US: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 117 TABLE 57 US: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 118 TABLE 58 US: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 118 TABLE 59 US: KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 119 TABLE 60 US: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 119 TABLE 61 CANADA: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 120 TABLE 62 CANADA: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 120 TABLE 63 CANADA: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 120 TABLE 64 CANADA: KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 121 TABLE 65 CANADA: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 121 TABLE 66 CANADA: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 122 TABLE 67 EUROPE: MACROECONOMIC OUTLOOK 123 TABLE 68 EUROPE: KNEE REPLACEMENT SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 69 EUROPE: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 124 TABLE 70 EUROPE: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 124 TABLE 71 EUROPE: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 124 TABLE 72 EUROPE: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 125 TABLE 73 EUROPE: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 125 TABLE 74 EUROPE: KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 126 TABLE 75 GERMANY: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 127 TABLE 76 GERMANY: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 127 TABLE 77 GERMANY: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 127 TABLE 78 GERMANY: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 128 TABLE 79 GERMANY: KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 128 TABLE 80 GERMANY: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 128 TABLE 81 FRANCE: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 129 TABLE 82 FRANCE: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 130 TABLE 83 FRANCE: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 130 TABLE 84 FRANCE: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 131 TABLE 85 FRANCE: KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 131 TABLE 86 FRANCE: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 132 TABLE 87 UK: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 133 TABLE 88 UK: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 133 TABLE 89 UK: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 133 TABLE 90 UK: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 134 TABLE 91 UK: KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 134 TABLE 92 UK: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 134 TABLE 93 ITALY: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 135 TABLE 94 ITALY: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 135 TABLE 95 ITALY: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 136 TABLE 96 ITALY: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 136 TABLE 97 ITALY: KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 137 TABLE 98 ITALY: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 137 TABLE 99 SPAIN: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 138 TABLE 100 SPAIN: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 138 TABLE 101 SPAIN: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 138 TABLE 102 SPAIN: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 139 TABLE 103 SPAIN: KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 139 TABLE 104 SPAIN: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 139 TABLE 105 REST OF EUROPE: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 140 TABLE 106 REST OF EUROPE: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 141 TABLE 107 REST OF EUROPE: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 141 TABLE 108 REST OF EUROPE: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 142 TABLE 109 REST OF EUROPE: KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 142 TABLE 110 REST OF EUROPE: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 143 TABLE 111 ASIA PACIFIC: MACROECONOMIC OUTLOOK 144 TABLE 112 ASIA PACIFIC: KNEE REPLACEMENT SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 113 ASIA PACIFIC: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 146 TABLE 114 ASIA PACIFIC: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 147 TABLE 115 ASIA PACIFIC: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 147 TABLE 116 ASIA PACIFIC: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 148 TABLE 117 ASIA PACIFIC: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 148 TABLE 118 ASIA PACIFIC: KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 149 TABLE 119 JAPAN: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 150 TABLE 120 JAPAN: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 150 TABLE 121 JAPAN: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 150 TABLE 122 JAPAN: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 151 TABLE 123 JAPAN: KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 151 TABLE 124 JAPAN: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 152 TABLE 125 CHINA: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 153 TABLE 126 CHINA: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 153 TABLE 127 CHINA: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 153 TABLE 128 CHINA: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 154 TABLE 129 CHINA: KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 154 TABLE 130 CHINA: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 155 TABLE 131 INDIA: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 156 TABLE 132 INDIA: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 156 TABLE 133 INDIA: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 156 TABLE 134 INDIA: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 157 TABLE 135 INDIA: KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 157 TABLE 136 INDIA: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 158 TABLE 137 AUSTRALIA: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 159 TABLE 138 AUSTRALIA: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 159 TABLE 139 AUSTRALIA: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 159 TABLE 140 AUSTRALIA: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 160 TABLE 141 AUSTRALIA: KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 160 TABLE 142 AUSTRALIA: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 161 TABLE 143 SOUTH KOREA: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 162 TABLE 144 SOUTH KOREA: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 162 TABLE 145 SOUTH KOREA: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 162 TABLE 146 SOUTH KOREA: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 163 TABLE 147 SOUTH KOREA: KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 163 TABLE 148 SOUTH KOREA: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 164 TABLE 149 REST OF ASIA PACIFIC: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 164 TABLE 150 REST OF ASIA PACIFIC: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 165 TABLE 151 REST OF ASIA PACIFIC: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 165 TABLE 152 REST OF ASIA PACIFIC: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 166 TABLE 153 REST OF ASIA PACIFIC: KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 166 TABLE 154 REST OF ASIA PACIFIC: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 167 TABLE 155 LATIN AMERICA: MACROECONOMIC OUTLOOK 168 TABLE 156 LATIN AMERICA: KNEE REPLACEMENT SURGERY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 157 LATIN AMERICA: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 169 TABLE 158 LATIN AMERICA: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 169 TABLE 159 LATIN AMERICA: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 169 TABLE 160 LATIN AMERICA: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 170 TABLE 161 LATIN AMERICA: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 170 TABLE 162 LATIN AMERICA: KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 171 TABLE 163 BRAZIL: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 172 TABLE 164 BRAZIL: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 172 TABLE 165 BRAZIL: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 172 TABLE 166 BRAZIL: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 173 TABLE 167 BRAZIL: KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 173 TABLE 168 BRAZIL: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 174 TABLE 169 MEXICO: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 175 TABLE 170 MEXICO: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 171 MEXICO: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 175 TABLE 172 MEXICO: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 176 TABLE 173 MEXICO: KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 176 TABLE 174 MEXICO: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 177 TABLE 175 REST OF LATIN AMERICA: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 177 TABLE 176 REST OF LATIN AMERICA: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 177 REST OF LATIN AMERICA: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 178 REST OF LATAM: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 179 TABLE 179 REST OF LATAM: KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 179 TABLE 180 REST OF LATAM: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 180 TABLE 181 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 181 TABLE 182 MIDDLE EAST & AFRICA: KNEE REPLACEMENT SURGERY MARKET, BY REGION, 2023–2030 (USD MILLION) 181 TABLE 183 MIDDLE EAST & AFRICA: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 182 TABLE 184 MIDDLE EAST & AFRICA: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 182 TABLE 185 MIDDLE EAST & AFRICA: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 183 TABLE 186 MIDDLE EAST & AFRICA: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 183 TABLE 187 MIDDLE EAST & AFRICA: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 184 TABLE 188 MIDDLE EAST & AFRICA: KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 184 TABLE 189 GCC COUNTRIES: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 185 TABLE 190 GCC COUNTRIES: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 185 TABLE 191 GCC COUNTRIES: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 186 TABLE 192 GCC COUNTRIES: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 186 TABLE 193 GCC COUNTRIES: KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 187 TABLE 194 GCC COUNTRIES: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 187 TABLE 195 REST OF MIDDLE EAST & AFRICA: KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 188 TABLE 196 REST OF MIDDLE EAST & AFRICA: KNEE IMPLANTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 188 TABLE 197 REST OF MIDDLE EAST & AFRICA: ORTHOBIOLOGICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 189 TABLE 198 REST OF MIDDLE EAST & AFRICA: KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 189 TABLE 199 REST OF MIDDLE EAST & AFRICA: KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2023–2030 (USD MILLION) 190 TABLE 200 REST OF MIDDLE EAST & AFRICA: KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 190 TABLE 201 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN KNEE REPLACEMENT SURGERY MARKET, 2022–2025 192 TABLE 202 KNEE REPLACEMENT SURGERY MARKET: DEGREE OF COMPETITION 194 TABLE 203 KNEE REPLACEMENT SURGERY MARKET: REGION FOOTPRINT 201 TABLE 204 KNEE REPLACEMENT SURGERY MARKET: PRODUCT FOOTPRINT 201 TABLE 205 KNEE REPLACEMENT SURGERY MARKET: APPLICATION FOOTPRINT 202 TABLE 206 KNEE REPLACEMENT SURGERY MARKET: PROCEDURE FOOTPRINT 203 TABLE 207 KNEE REPLACEMENT SURGERY MARKET: END-USER FOOTPRINT 203 TABLE 208 KNEE REPLACEMENT SURGERY MARKET: DETAILED LIST OF KEY STARTUPS/SMES 206 TABLE 209 KNEE REPLACEMENT SURGERY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 207 TABLE 210 KNEE REPLACEMENT SURGERY MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–MAY 2025 208 TABLE 211 KNEE REPLACEMENT SURGERY MARKET: DEALS, JANUARY 2022–MAY 2025 209 TABLE 212 ZIMMER BIOMET: COMPANY OVERVIEW 211 TABLE 213 ZIMMER BIOMET: PRODUCTS OFFERED 212 TABLE 214 ZIMMER BIOMET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022−MAY 2025 213 TABLE 215 ZIMMER BIOMET HOLDINGS: DEALS, JANUARY 2022−MAY 2025 214 TABLE 216 STRYKER: COMPANY OVERVIEW 215 TABLE 217 STRYKER: PRODUCTS OFFERED 216 TABLE 218 STRYKER: DEALS, JANUARY 2022−MAY 2025 217 TABLE 219 STRYKER: EXPANSIONS, JANUARY 2022−MAY 2025 217 TABLE 220 JOHNSON & JOHNSON MEDTECH: COMPANY OVERVIEW 219 TABLE 221 JOHNSON & JOHNSON MEDTECH: PRODUCTS OFFERED 220 TABLE 222 JOHNSON & JOHNSON MEDTECH: DEALS, JANUARY 2022−MAY 2025 221 TABLE 223 SMITH+NEPHEW: COMPANY OVERVIEW 222 TABLE 224 SMITH+NEPHEW: PRODUCTS OFFERED 223 TABLE 225 SMITH+NEPHEW: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022−MAY 2025 224 TABLE 226 SMITH+NEPHEW: DEALS, JANUARY 2022−MAY 2025 224 TABLE 227 SMITH+NEPHEW: EXPANSIONS, JANUARY 2022−MAY 2025 224 TABLE 228 B. BRAUN SE: COMPANY OVERVIEW 226 TABLE 229 B. BRAUN SE: PRODUCTS OFFERED 227 TABLE 230 B. BRAUN SE: DEALS, JANUARY 2022−MAY 2025 228 TABLE 231 GLOBUS MEDICAL: COMPANY OVERVIEW 230 TABLE 232 GLOBUS MEDICAL: PRODUCTS OFFERED 231 TABLE 233 GLOBUS MEDICAL: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022−MAY 2025 232 TABLE 234 GLOBUS MEDICAL: DEALS, JANUARY 2022−MAY 2025 232 TABLE 235 ENOVIS: COMPANY OVERVIEW 233 TABLE 236 ENOVIS: PRODUCTS OFFERED 234 TABLE 237 ENOVIS: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022−MAY 2025 236 TABLE 238 ENOVIS: DEALS, JANUARY 2022−MAY 2025 236 TABLE 239 ENOVIS: EXPANSIONS, JANUARY 2022−MAY 2025 237 TABLE 240 MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW 238 TABLE 241 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED 239 TABLE 242 MICROPORT SCIENTIFIC CORPORATION: DEALS, JANUARY 2022−MAY 2025 240 TABLE 243 MEDACTA INTERNATIONAL: COMPANY OVERVIEW 241 TABLE 244 MEDACTA INTERNATIONAL: PRODUCTS OFFERED 242 TABLE 245 MEDACTA INTERNATIONAL: DEALS, JANUARY 2022−MAY 2025 243 TABLE 246 MEDACTA INTERNATIONAL: EXPANSIONS, JANUARY 2022−MAY 2025 243 TABLE 247 MAXX ORTHOPEDICS, INC.: COMPANY OVERVIEW 244 TABLE 248 MAXX ORTHOPEDICS, INC.: PRODUCTS OFFERED 244 TABLE 249 MAXX ORTHOPEDICS, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022− MAY 2025 244 TABLE 250 MAXX ORTHOPEDICS, INC.: DEALS, JANUARY 2022–MAY 2025 245 TABLE 251 MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW 246 TABLE 252 MERIL LIFE SCIENCES PVT. LTD.: PRODUCTS OFFERED 246 TABLE 253 MERIL LIFE SCIENCES PVT. LTD.: EXPANSIONS, JANUARY 2022−MAY 2025 247 TABLE 254 WALDEMAR LINK GMBH & CO. KG: COMPANY OVERVIEW 248 TABLE 255 WALDEMAR LINK GMBH & CO. KG: PRODUCTS OFFERED 248 TABLE 256 EXACTECH, INC.: COMPANY OVERVIEW 249 TABLE 257 EXACTECH, INC.: PRODUCTS OFFERED 249 TABLE 258 EXACTECH, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022−MAY 2025 250 TABLE 259 EXACTECH, INC.: DEALS, JANUARY 2022−MAY 2025 250 TABLE 260 AMPLITUDE SURGICAL: COMPANY OVERVIEW 251 TABLE 261 AMPLITUDE SURGICAL: PRODUCTS OFFERED 251 TABLE 262 AMPLITUDE SURGICAL: DEALS, JANUARY 2022–MAY 2025 252 TABLE 263 RESTOR3D: COMPANY OVERVIEW 253 TABLE 264 RESTOR3D: PRODUCTS OFFERED 253 TABLE 265 RESTOR3D: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022−MAY 2025 253 TABLE 266 BAUERFEIND: COMPANY OVERVIEW 254 TABLE 267 AK MEDICAL: COMPANY OVERVIEW 255 TABLE 268 DOUBLE MEDICAL TECHNOLOGY INC.: COMPANY OVERVIEW 256 TABLE 269 OLYMPUS CORPORATION: COMPANY OVERVIEW 257 TABLE 270 BIORAD MEDISYS PVT. LTD.: COMPANY OVERVIEW 258 TABLE 271 UNITED ORTHOPEDIC CORPORATION: COMPANY OVERVIEW 259 TABLE 272 ALLEGRA: COMPANY OVERVIEW 260 TABLE 273 TOTAL JOINT ORTHOPEDICS: COMPANY OVERVIEW 260 TABLE 274 THUASNE GROUP: COMPANY OVERVIEW 261 TABLE 275 EMBLA MEDICAL: COMPANY OVERVIEW 262 FIGURE 1 KNEE REPLACEMENT SURGERY MARKET AND REGIONAL SCOPE 27 FIGURE 2 KNEE REPLACEMENT SURGERY MARKET: RESEARCH DESIGN 30 FIGURE 3 KNEE REPLACEMENT SURGERY MARKET: MARKET RESEARCH METHODOLOGY 31 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS 35 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 36 FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 37 FIGURE 7 KNEE REPLACEMENT SURGERY MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION) 38 FIGURE 8 KNEE REPLACEMENT SURGERY MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 39 FIGURE 9 TOP-DOWN APPROACH 40 FIGURE 10 DATA TRIANGULATION 42 FIGURE 11 KNEE REPLACEMENT SURGERY MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 45 FIGURE 12 KNEE REPLACEMENT SURGERY MARKET, BY PROCEDURE, 2025 VS. 2030 (USD MILLION) 46 FIGURE 13 KNEE REPLACEMENT SURGERY MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 46 FIGURE 14 KNEE REPLACEMENT SURGERY MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 47 FIGURE 15 GEOGRAPHIC SNAPSHOT OF KNEE REPLACEMENT SURGERY MARKET 48 FIGURE 16 RISING PREVALENCE OF KNEE DISEASES AND INCREASING GERIATRIC POPULATION TO DRIVE MARKET 49 FIGURE 17 KNEE IMPLANTS SEGMENT TO REGISTER SIGNIFICANT GROWTH IN NORTH AMERICAN MARKET DURING FORECAST PERIOD 50 FIGURE 18 TOTAL KNEE REPLACEMENT SEGMENT TO DOMINATE EUROPEAN MARKET DURING FORECAST PERIOD 50 FIGURE 19 HOSPITALS SEGMENT TO LEAD END-USER MARKET IN ASIA PACIFIC DURING FORECAST PERIOD 51 FIGURE 20 JAPAN TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 51 FIGURE 21 KNEE REPLACEMENT SURGERY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 52 FIGURE 22 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 58 FIGURE 23 AVERAGE SELLING PRICE OF KNEE REPLACEMENT SURGERY PRODUCTS, 2024 (USD) 59 FIGURE 24 AVERAGE SELLING PRICE OF KNEE SURGERY PRODUCTS, BY REGION, 2024 (USD) 60 FIGURE 25 KNEE REPLACEMENT SURGERY MARKET: VALUE CHAIN ANALYSIS 62 FIGURE 26 KNEE REPLACEMENT SURGERY MARKET: SUPPLY CHAIN ANALYSIS 63 FIGURE 27 KNEE REPLACEMENT SURGERY MARKET: ECOSYSTEM ANALYSIS 64 FIGURE 28 INVESTMENT AND FUNDING SCENARIO, 2019−2023 (USD MILLION) 65 FIGURE 29 NUMBER OF INVESTOR DEALS IN KNEE REPLACEMENT SURGERY MARKET, BY KEY PLAYER, 2019−2023 66 FIGURE 30 VALUE OF INVESTOR DEALS IN KNEE REPLACEMENT SURGERY MARKET, BY KEY PLAYER, 2019–2023 (USD MILLION) 66 FIGURE 31 KNEE REPLACEMENT SURGERY MARKET: PATENT ANALYSIS, 2014–2025 68 FIGURE 32 IMPORT DATA FOR HS CODE 902110, BY COUNTRY, 2021–2024 (USD THOUSAND) 70 FIGURE 33 EXPORT DATA FOR HS CODE 902110, BY COUNTRY, 2021–2024 (USD THOUSAND) 71 FIGURE 34 KNEE REPLACEMENT SURGERY MARKET: PORTER’S FIVE FORCES ANALYSIS 75 FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 76 FIGURE 36 KEY BUYING CRITERIA, BY END USER 77 FIGURE 37 KNEE REPLACEMENT SURGERY MARKET: AI USE CASES 79 FIGURE 38 NORTH AMERICA: KNEE REPLACEMENT SURGERY MARKET SNAPSHOT 113 FIGURE 39 ASIA PACIFIC: KNEE REPLACEMENT SURGERY MARKET SNAPSHOT 145 FIGURE 40 REVENUE ANALYSIS OF KEY PLAYERS IN KNEE REPLACEMENT SURGERY MARKET, 2021−2024 193 FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS IN KNEE REPLACEMENT SURGERY MARKET, 2024 194 FIGURE 42 RANKING OF KEY PLAYERS IN KNEE REPLACEMENT SURGERY MARKET, 2024 195 FIGURE 43 EV/EBITDA OF KEY VENDORS, 2025 196 FIGURE 44 5-YEAR STOCK BETA OF KEY VENDORS, 2025 196 FIGURE 45 KNEE REPLACEMENT SURGERY MARKET: BRAND/PRODUCT COMPARISON 197 FIGURE 46 KNEE REPLACEMENT SURGERY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 199 FIGURE 47 KNEE REPLACEMENT SURGERY MARKET: COMPANY FOOTPRINT 200 FIGURE 48 KNEE REPLACEMENT SURGERY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 205 FIGURE 49 ZIMMER BIOMET: COMPANY SNAPSHOT (2024) 212 FIGURE 50 STRYKER: COMPANY SNAPSHOT (2023) 216 FIGURE 51 JOHNSON & JOHNSON MEDTECH: COMPANY SNAPSHOT (2024) 220 FIGURE 52 SMITH+NEPHEW: COMPANY SNAPSHOT (2024) 223 FIGURE 53 B. BRAUN SE: COMPANY SNAPSHOT (2024) 227 FIGURE 54 GLOBUS MEDICAL: COMPANY SNAPSHOT (2024) 231 FIGURE 55 ENOVIS: COMPANY SNAPSHOT (2024) 234 FIGURE 56 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2024) 239 FIGURE 57 MEDACTA INTERNATIONAL: COMPANY SNAPSHOT (2024) 242 FIGURE 58 AMPLITUDE SURGICAL: COMPANY SNAPSHOT (2024) 252

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們